| 1 |
Hosseinian L, Weiner M, Levin MA, et al. Methylene blue: Magic bullet for vasoplegia？[J]. Anesth Analg, 2016，122(1)：194-201.
|
| 2 |
Shaefi S, Mittel A, Klick J, et al. Vasoplegia after cardiovascular procedures-pathophysiology and targeted therapy[J]. J Cardiothorac Vasc Anesth, 2018, 32(2): 1013-1022.
|
| 3 |
Tsiouris A, Wilson L, Haddadin AS, et al. Risk assessment and outcomes of vasoplegia after cardiac surgery[J]. Gen Thorac Cardiovasc Surg, 2017，65(10): 557-565.
|
| 4 |
Khosravi MB, Milani S, Ghaffaripour S, et al. Very high dose epinephrine for the treatment of vasoplegic syndrome during liver transplantation[J]. Int J Organ Transplant Med, 2013, 4(1): 32-34.
|
| 5 |
An SS, Henson CP, Freundlich RE, et al. Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation[J]. Am J Transplant, 2018，18(6): 1552-1555.
|
| 6 |
Fischer GW, Bengtsson Y, Scarola S, et al. Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation[J]. J Cardiothorac Vasc Anesth, 2010, 24(3): 463-466.
|
| 7 |
Mourad MM, Liossis C, Gunson BK, et al. Etiology and management of hepatic artery thrombosis after adult liver transplantation[J]. Liver Transpl, 2014, 20(6): 713-723.
|
| 8 |
Willuweit K, Bezinover D, Herzer K, et al. Efficacy of IgM-enriched immunoglobulin for vasopressor-resistant vasoplegic shock after liver transplantation[J]. Transplantation, 2019, 103(2): 381-386.
|
| 9 |
Lominchar PL, Orue-Echebarria MI, Martin L, et al. Hepatic flow is an intraoperative predictor of early allograft dysfunction in whole-graft deceased donor liver transplantation: An observational cohort study[J]. World J Hepatol, 2019, 11(9): 689-700.
|
| 10 |
Fischer GW, Levin MA. Vasoplegia during cardiac surgery: current concepts and management[J]. Semin Thorac Cardiovasc Surg, 2010, 22(2): 140-144.
|
| 11 |
Liu H, Yu L, Yang L, et al. Vasoplegic syndrome: An update on perioperative considerations[J]. J Clin Anesth, 2017, 40: 63-71.
|
| 12 |
Orozco VD, Triana SC, Orozco VA. Vasoplegic syndrome in cardiac surgery: Definitions, pathophysiology, diagnostic approach and management[J]. Rev Esp Anestesiol Reanim, 2019, 66(5): 277-287.
|
| 13 |
Shapeton AD, Mahmood F, Ortoleva JP. Hydroxocobalamin for the treatment of vasoplegia: A review of current literature and considerations for use[J]. J Cardiothorac Vasc Anesth, 2019, 33(4): 894-901.
|
| 14 |
Levy B, Fritz C, Tahon E, et al. Vasoplegia treatments: The past, the present, and the future[J]. Crit Care, 2018, 22(1): 52.
|
| 15 |
Bezinover D, McQuillan P, Rossignol J, et al. Vasoplegic shock during liver transplantation: is the preoperative cGMP plasma level a potential predictor of hemodynamic instability？[J]. Med Sci Monit, 2010，16(9): S114-S117.
|
| 16 |
Wagener G, Kovalevskaya G, Minhaz M, et al. Vasopressin deficiency and vasodilatory state in end-stage liver disease[J]. J Cardiothorac Vasc Anesth, 2011, 25(4): 665-670.
|
| 17 |
Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: The VANCS randomized controlled trial[J]. Anesthesiology, 2017，126(1): 85-93.
|
| 18 |
Busse LW, Barker N, Petersen C. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options[J]. Crit Care, 2020, 24(1): 36.
|
| 19 |
石屹崴，于洪丽，张桂诚，等. 亲体肾移植术肾动脉开放后血管麻痹综合征1例[J]. 江苏医药，2021, 47(8): 860-862.
|
| 20 |
Bussard RL, Busse LW. Angiotensin II: a new therapeutic option for vasodilatory shock[J]. Ther Clin Risk Manag, 2018, 14: 1287-1298.
|
| 21 |
Russell JA, Vincent JL, Kjolbye AL, et al. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients[J]. Crit Care, 2017, 21(1): 213.
|
| 22 |
Prakash V, Choudhury AK, Sarin SK. Early introduction of a combination of low dose terlipressin and noradrenaline as vasopressors is superior to high dose noradrenaline alone in patients of cirrhosis with septic shock[J]. Hepatology, 2017, 66: 138A.
|
| 23 |
Rodriguez R, Cucci M, Kane S, et al. Novel vasopressors in the treatment of vasodilatory shock: A systematic review of angiotensin II, selepressin, and terlipressin[J]. J Intensive Care Med, 2020, 35(4): 327-337.
|
| 24 |
Woolum JA, Abner EL, Kelly A, et al. Effect of thiamine administration on lactate clearance and mortality in patients with septic shock[J]. Crit Care Med, 2018, 46: 1747-1752.
|
| 25 |
Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study[J]. Chest, 2017, 151(6): 1229-1238.
|